A comparative study of top-down and bottom-up approaches for the preparation of nanosuspensions of glipizide

Powder Technology

Volumn 256, Issue , 2014, Pages 436-449

  Mahesh, Koneti Venkata ^a   Singh, Sachin Kumar ^a   Gulati, Monica ^a  

^a LOVELY PROFESSIONAL UNIVERSITY   (India)

Author keywords

Glipizide; Liquid antisolvent precipitation; Media milling; Nanosuspensions; Particle size distribution d (90); Zeta potential

Indexed keywords

LIQUIDS; MIXING; PARTICLE SIZE ANALYSIS; PRECIPITATION (CHEMICAL); X RAY DIFFRACTION; ZETA POTENTIAL;

DISSOLUTION PROFILES; GLIPIZIDE; LIQUID ANTISOLVENT; MEDIA MILLINGS; NANO-SIZED PARTICLES; NANO-SUSPENSIONS; PROCESSING PARAMETERS; X-RAY DIFFRACTION DATA;

MILLING (MACHINING);

GLIPIZIDE; POLYMER;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; DRUG MIXTURE; DRUG SOLUBILITY; LIQUID ANTISOLVENT PRECIPITATION; NANOPHARMACEUTICS; NANOSUSPENSION; PARTICLE SIZE; PRECIPITATION; PROCESS CONTROL; REACTION OPTIMIZATION; REACTION TIME; SUSPENSION; TEMPERATURE SENSITIVITY; X RAY DIFFRACTION; ZETA POTENTIAL;

EID: 84896389562     PISSN: 00325910     EISSN: 1873328X     Source Type: Journal    
DOI: 10.1016/j.powtec.2014.02.011     Document Type: Article

References (21)

1. Kesisoglou F., Panmai S., Wu Y. Nanosizing-oral formulation development and biopharmaceutical evaluation. Adv. Drug Deliv. Rev. 2007, 59:631-644.
2. Patravale V.B., Date A.A., Kulkarni R.M. Nanosuspensions: a promising drug delivery strategy. J. Pharm. Pharmacol. 2004, 56:827-840.
3. Rabinow B.E. Nanosuspensions in drug delivery. Nat. Rev. Drug Discov. 2004, 3:785-796.
4. Eerdenbrugh B.V., Van den Mooter G., Augustijns P. Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products. Int. J. Pharm. 2008, 364:64-75.
5. Date A.A., Patravale V.B. Current strategies for engineering drug nanoparticles. Curr. Opin. Colloid Interface Sci. 2004, 9:222-235.
6. Parsons G.E., Buckton G., Chatham S.M. The use of surface energy and polarity determinations to predict physical stability of non-polar, non-aqueous suspensions. Int. J. Pharm. 1992, 83:163-170.
7. Phillips E.M., Bryon P.R. Surfactant promoted crystal growth of micronized methylprednisolone in trichloromonofluoromethane. Int. J. Pharm. 1994, 110:9-19.
8. Williams R.O., Brown J., Liu J. Influence of micronization method on the performance of a suspension triamcinolone acetonide pressurized metered dose inhaler formulation. Pharm. Dev. Technol. 1999, 4:167-179.
9. Hütterauch R., Fricke S., Zielke P. Mechanical activation of pharmaceutical systems. Pharm. Res. 1985, 2:302-306.
10. Heng J.Y.Y., Thielmann F., Williams D.R. The effects of milling on the surface properties of form I paracetamol crystals. Pharm. Res. 2006, 23:1918-1927.
11. Verma S., Gokhale R., Burgess D.J. A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions. Int. J. Pharm. 2009, 380:216-222.
12. Muller R.H., Jacobs C., Kayser O. Nanosuspensions as particulate drug formulations in therapy: rationale for development and what we can expect for the future. Adv. Drug Deliv. Rev. 2001, 47(2001):3-19.
13. Singh S.K., Srinivasan K.K., Gowthamarajan K., Singare D.S., Prakash D., Gaikwad N.B. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide. Eur. J. Pharm. Biopharm. 2011, 78:441-446.
14. Bilati U., Allemann E., Doelker E. Development of a nanoprecipitation method intended for the entrapment of hydrophilic drugs into nanoparticles. Eur. J. Pharm. Sci. 2005, 24:67-75.
15. Thorat A.A., Dalvi S.V. Liquid antisolvent precipitation and stabilization of nanoparticles of poorly water soluble drugs in aqueous suspensions: recent developments and future perspective. Chem. Eng. J. 2012, 181(182):1-34.
16. Kakran M., Sahoo N.G., Lia L., Judeh Z., Wang Y., Chong K. Fabrication of drug nanoparticles by evaporative precipitation of nanosuspension. Int. J. Pharm. 2010, 383:285-292.
17. Zeng H., Li X., Zhang G., Dong J. Preparation and characterization of betacypermethrin nanosuspensions by diluting O/W microemulsions. J. Dispers. Sci. Technol. 2008, 29:358-361.
18. Kim M.S., Jin S.J., Kim J.S., Park H.J., Song H.S., Neubert R.H.H., Hwang S.J. Preparation, characterization and in vivo evaluation of amorphous atorvastatin calcium nanoparticles using supercritical antisolvent (SAS) process. Eur. J. Pharm. Biopharm. 2008, 69:454-465.
19. Singare D.S., Marella S., Gowthamarajan K., Kulkarni G.T., Vooturi R., Rao P.S. Optimization of formulation and process variable of nanosuspension: an industrial perspective. Int. J. Pharm. 2010, 402:213-220.
20. Otoom S., Hasan M., Najib N. The bioavailability of glyburide (glibenclamide) under fasting and feeding conditions: a comparative study. Int. J. Pharm. Med. 2001, 15:117-120.
21. Davis S., Granner D. Insulin, oral hypoglycemic agents and the pharmacology of the endocrine pancreas. Goodman and Gilman's: The Pharmacologic Basis of Therapeutics 1996, 1487-1518. McGraw-Hill, New York, NY. 9th ed. J.G. Hardman, L.E. Limbird (Eds.).